RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou, Kyung W. Song, Ivana Yen et al. · Nature · 2010
Cited by 1,622 works. doi:10.1038/nature08833
Authors
- Georgia Hatzivassiliou
- Kyung W. Song
- Ivana Yen
- Barbara J. Brandhuber
- Daniel J. Anderson
- Mary J. C. Ludlam
- David Stokoe
- Susan L. Gloor
- Guy P. A. Vigers
- Tony H Morales
- Ignacio Aliagas
- Bonnie Liu
- Steve Sideris
- Klaus P. Hoeflich
- Bijay Shankar Jaiswal
- Somasekar Seshagiri
- Hartmut Koeppen
- Marcia P. Belvin
- Lori S. Friedman
References
- The CCP4 suite: programs for protein crystallography
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
- Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
- Fluorescent proteins from nonbioluminescent Anthozoa species
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- The RAF proteins take centre stage
- Hyperactive Ras in developmental disorders and cancer
- Natural Animal Coloration Can Be Determined by a Nonfluorescent Green Fluorescent Protein Homolog
- A dimerization-dependent mechanism drives RAF catalytic activation
- Phase I study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer